Why Has Stifel Given MAXIMUS (NYSE:MMS) a $65 Price Target
In a recent report distributed today, Stifel analysts have begun MAXIMUS (NYSE:MMS) coverage with “Buy” rating, and a $65 PT.
From a total of 6 analysts covering MAXIMUS (NYSE:MMS) stock, 5 rate it a ”Buy”, 0 a “Sell”, and 3 a ”Hold”. This means that 63% of the ratings are positive. The highest target price is $87 while the lowest target price is $59. The mean of all analyst targets is $71 with a 24.75% above today’s ($57.45) stock price. MAXIMUS was the topic of 8 analyst reports since August 6, 2015 according to the firm StockzIntelligence Inc. Maxim Group maintained shares on November 12 with “Buy” rating.
The stock decreased 0.09% or $0.05 on December 3, striking $57.45. Approximately shares of stock traded hands. MAXIMUS, Inc. (NYSE:MMS) has declined 11.19% since May 1, 2015 and is downtrending. It has underperformed by 8.41% the S&P500.
MAXIMUS, Inc. provides business process services to Government health and human services agencies. The company has a market cap of $3.75 billion. The Firm is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs. It has 24.58 P/E ratio. It provides health and human services to Governments in the United States, Australia, Canada, the United Kingdom and Saudi Arabia.
According to Zacks Investment Research, “MAXIMUS, Inc. is an extremely dynamic and complex organization that offers government and industry a range of unique services, products, and solutions. The diverse services and products that MAXIMUS offers may be categorized into three groups: Government Program Management and Operations, Consulting, and Systems. Government Program Management and Operations focuses on having a measurable impact on the lives of the citizens we help government serve. The insights of MAXIMUS Consulting, and the technological innovations advanced through Systems, help government gain program efficiencies and pursue improvements that in turn benefit citizens.” Get a free copy of the Zacks research report on MAXIMUS, Inc. (MMS).